Use of cytomegalovirus antigenemia as a marker for preemptive treatment
- 1 February 2002
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (1) , 67-68
- https://doi.org/10.1016/s0041-1345(01)02668-9
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Infectious disease complications of renal transplantationKidney International, 1993
- New Developments in Cytomegalovirus Prevention and ManagementAmerican Journal of Kidney Diseases, 1993
- Management and Prevention of Cytomegalovirus Infection After Renal TransplantationMayo Clinic Proceedings, 1992
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987